Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.

Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B

NCT00071201 ·Status: COMPLETED ·Phase: PHASE3

Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection

NCT02258581 ·Status: TERMINATED

A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B

NCT00117676 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

NCT00537537 ·Status: COMPLETED ·Phase: PHASE4

Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B

NCT01270165 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B

NCT00116805 ·Status: COMPLETED ·Phase: PHASE3

Suboptimal Responders to Adefovir Switching to Entecavir

NCT00718887 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation

NCT00065507 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil

NCT00307489 ·Status: COMPLETED ·Phase: PHASE2

An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)

NCT01205165 ·Status: COMPLETED ·Phase: PHASE4

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)

NCT05630807 ·Status: COMPLETED ·Phase: PHASE3

HBV Reactivation in Anti CD20 Treatment

NCT05768061 ·Status: UNKNOWN

Efficacy Study of Telbivudine in Chronic Hepatitis B Patients

NCT01958229 ·Status: COMPLETED

Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.

NCT03241641 ·Status: COMPLETED ·Phase: PHASE4

ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy

NCT00823342 ·Status: TERMINATED ·Phase: PHASE3

Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders

NCT00704106 ·Status: COMPLETED

Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients

NCT01356901 ·Status: COMPLETED

Drug Use Investigation for HEPSERA (Adefovir) Tablet

NCT01863589 ·Status: COMPLETED

A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B

NCT03258710 ·Status: COMPLETED ·Phase: PHASE4

Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis

NCT00347009 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study

NCT01804387 ·Status: UNKNOWN ·Phase: PHASE4

Optimizing HBV Management During Anti-CD20 Antibodies

NCT03155984 ·Status: COMPLETED

Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed

NCT02979613 ·Status: COMPLETED ·Phase: PHASE3

Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B

NCT01595685 ·Status: COMPLETED ·Phase: PHASE3

Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine

NCT00640588 ·Status: COMPLETED ·Phase: PHASE3